Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01596179 · ClinicalTrials.gov registry record · Phase 3
Technology Enhanced Nurse Navigator Trial (TENN Trial)
A Phase 3 study, sponsored by Mercy Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 101
- Enrollment target
NCT01596179: Completed Phase 3 study, sponsored by Mercy Medical Center.
NCT01596179 is a Phase 3 study that has completed, run by Mercy Medical Center. The registered enrollment target is 101 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01596179, a Phase 3 study, has completed, sponsored by Mercy Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of the Technology Enhanced Nurse Navigator Trial (TENN) Trial is to find the best way to provide breast cancer patients with information through a computer connected to the internet. The study will determine if giving information during treatment may help patients cope better with their treatment. The hypothesis is that participants assigned to receive Technology-Enhanced Nurse-directed Navigation will be more likely to adhere to treatment regimens and have improved symptom management than women who have access to the education portal only.
Primary Outcome
Adherence will be determined by review of the claims data. All claims, including hormone, chemotherapy and radiation therapy, doctor's visits, and hospitalizations, are sent through the BCCDT program. For chemotherapy and radiation therapy, relative dose intensity (RDI) will be measured. Adherence to hormone therapy will be measured as the medication possession ratio (MPR).A self-reported measure of adherence will be correlated with these more objective measures (Morisky et al. 1986).
Interventions
- BEHAVIORAL Interactive navigational support
- BEHAVIORAL Internet access
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-02 |
| Phase | Phase 3 |
What the finished NCT01596179 record still lists
NCT01596179 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Interactive navigational support is the first listed.
NCT01596179 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01596179 about?
NCT01596179 is a clinical study titled "Technology Enhanced Nurse Navigator Trial (TENN Trial)". The purpose of the Technology Enhanced Nurse Navigator Trial (TENN) Trial is to find the best way to provide breast cancer patients with information through a computer connected to the internet. The study will determine if giving information during treatment may help patients cope better with their ...
What is the current status of trial NCT01596179?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 101 participants. The study started on 2012-02. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01596179?
The interventions under investigation include: Interactive navigational support (BEHAVIORAL), Internet access (BEHAVIORAL).
Who is sponsoring clinical trial NCT01596179?
This trial is sponsored by Mercy Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01596179's enrollment target sits among peer trials
101 1680th of 2000 higher than 320 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia